Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Neoplasms 3Solid Tumors 2Lung Neoplasms 2Breast Neoplasms 2Advanced Solid Tumors 2Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Histologically or Cytologically Documented Solid Tumors 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

motesanib diphosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Histologically or Cytologically Documented Solid Tumors × motesanib diphosphate × Clear all
NCT01235416 2011-01-21

A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors

Amgen

Phase 1 Completed
57 enrolled
Other solid neoplasm

Histologically or Cytologically Documented Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡